Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Scientist Pipetting Liquids for Research
New FIX Chromogenic Assay Launched by Precision BioLogic
Jan 18, 2023
Industry
Biomarin Provides Hemophilia A Clinical Development Program Updates
Biomarin Provides Hemophilia A Clinical Development Program Updates
Jan 10, 2023
Industry
Takeda Announces Trial Results on Investigational Therapy for Ultra Rare Blood Disorder
Takeda Announces Trial Results on Investigational Therapy for…
Jan 10, 2023
Industry
Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy
Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy…
Jan 4, 2023
Industry
Clinical Trial Lab Research
Spark Announces SPK-8011 Updates at ASH
Dec 15, 2022
Medical
gene therapy
First Hemophilia B Gene Therapy Approved by FDA
Nov 23, 2022
Medical
New Document to Help Residential Substance Use Disorder Placement for Individuals with Bleeding Disorders
New Document to Help Residential Substance…
Nov 14, 2022
Industry
BioMarin Shares Community Update for Valoctocogene Roxaparvovec
BioMarin Shares Community Update for Valoctocogene Roxaparvovec
Oct 3, 2022
Industry
Clinical Trial Gene Therapy Double Helix
Recruitment Reopened for Phase 3 AFFINE Gene Therapy Trial
Sep 23, 2022
Medical
Clinical Trial Gene Double Helix
Update for the Hemophilia Community
Sep 12, 2022
Medical
Person interacting with computer and taking notes
Virtual Grand Round Series to Focus on Hemophilia Gene Therapy
Sep 12, 2022
Industry
Red Blood Cells
FDA Grants Priority Review for Sanofi’s BIVV001
Sep 6, 2022
Industry
Doctor asking questions to patient about care
Rare Factor X Deficiency Survey Shows Disparity in Care
Sep 1, 2022
Industry
Gene Helix for Gene Therapy Image
BioMarin Receives Conditional Approval in Europe for Gene Therapy
Aug 25, 2022
Medical
PPTA Posts Statement on Monkeypox and Plasma Protein Therapies
PPTA Posts Statement on Monkeypox and Plasma Protein Therapies
Aug 22, 2022